Quick Takeaways
- K2 HealthVentures Equity Trust LLC filed SCHEDULE 13G for Alto Neuroscience, Inc. Common Stock, $0.0001 par value per share (ANRO).
- Disclosed ownership: 5.6%.
- Date of event: 13 Jan 2025.
K2 HealthVentures Equity Trust LLC - 13 Jan 2025 SCHEDULE 13G Report for Alto Neuroscience, Inc. Common Stock, $0.0001 par value per share (ANRO)
- Filing Manager
- K2 HealthVentures Equity Trust LLC
- Reporting Manager
- K2 HealthVentures Equity Trust LLC
- Symbol
- ANRO
- Shares outstanding
- 28,890,268 shares
- Disclosed Ownership
- 1,617,855 shares
- Ownership
- 5.6%
- Form type
- SCHEDULE 13G
- Filing time
- 15 May 2025, 15:19:13 UTC
- Date of event
- 13 Jan 2025
- Next filing
- 17 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"K2 HealthVentures Equity Trust LLC disclosed 5.6% ownership in Alto Neuroscience, Inc. Common Stock, $0.0001 par value per share (ANRO) on 13 Jan 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 15 May 2025, 15:19.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| K2 HealthVentures Equity Trust LLC | 5.6% | 1,617,855 | 0 | 1,617,855 | /s/ Anup Arora | Anup Arora, Managing Member | |
| Parag Shah | 5.6% | 1,617,855 | 0 | 1,617,855 | /s/ Parag Shah | Parag Shah | |
| Anup Arora | 5.6% | 1,617,855 | 0 | 1,617,855 | /s/ Anup Arora | Anup Arora |